FDMT logo

FDMT Cash From Operations

Annual CFO

-$134.59 M
-$58.79 M-77.57%

December 1, 2024


Summary


Performance

FDMT Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFDMTcash flowmetrics:

Quarterly CFO

-$45.86 M
-$16.47 M-56.04%

December 1, 2024


Summary


Performance

FDMT Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFDMTcash flowmetrics:

TTM CFO

-$134.59 M
-$21.21 M-18.71%

December 1, 2024


Summary


Performance

FDMT TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFDMTcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

FDMT Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-77.6%-51.6%-58.0%
3 y3 years-94.7%-3816.6%-83.5%
5 y5 years-266.6%-3816.6%-83.5%

FDMT Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-94.7%at low-3816.6%at low-94.7%at low
5 y5-year-266.6%at low-3816.6%at low-870.3%at low
alltimeall time-1733.9%at low-3816.6%at low-870.3%at low

4D Molecular Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$134.59 M(+77.6%)
-$45.86 M(+56.0%)
-$134.59 M(+18.7%)
Sep 2024
-
-$29.39 M(-2.8%)
-$113.37 M(+33.1%)
Jun 2024
-
-$30.24 M(+4.0%)
-$85.15 M(+10.6%)
Mar 2024
-
-$29.09 M(+18.0%)
-$76.97 M(+1.6%)
Dec 2023
-$75.79 M(-12.6%)
-$24.65 M(+2005.0%)
-$75.79 M(+3.3%)
Sep 2023
-
-$1.17 M(-94.7%)
-$73.36 M(-21.3%)
Jun 2023
-
-$22.07 M(-20.9%)
-$93.20 M(+2.4%)
Mar 2023
-
-$27.91 M(+25.6%)
-$91.04 M(+5.0%)
Dec 2022
-$86.69 M
-$22.21 M(+5.7%)
-$86.69 M(+0.4%)
Sep 2022
-
-$21.02 M(+5.6%)
-$86.31 M(+6.5%)
Jun 2022
-
-$19.90 M(-15.5%)
-$81.01 M(+4.8%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$23.55 M(+7.8%)
-$77.31 M(+11.8%)
Dec 2021
-$69.13 M(+35.8%)
-$21.84 M(+38.9%)
-$69.13 M(+6.7%)
Sep 2021
-
-$15.72 M(-3.0%)
-$64.80 M(+3.8%)
Jun 2021
-
-$16.20 M(+5.4%)
-$62.45 M(+19.1%)
Mar 2021
-
-$15.37 M(-12.2%)
-$52.41 M(+3.0%)
Dec 2020
-$50.91 M(+38.7%)
-$17.50 M(+30.9%)
-$50.91 M(+52.4%)
Sep 2020
-
-$13.37 M(+116.7%)
-$33.41 M(+66.7%)
Jun 2020
-
-$6.17 M(-55.5%)
-$20.04 M(+44.5%)
Mar 2020
-
-$13.87 M
-$13.87 M
Dec 2019
-$36.71 M(+125.9%)
-
-
Dec 2018
-$16.25 M(-297.3%)
-
-
Dec 2017
$8.24 M
-
-

FAQ

  • What is 4D Molecular Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for 4D Molecular Therapeutics?
  • What is 4D Molecular Therapeutics annual CFO year-on-year change?
  • What is 4D Molecular Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for 4D Molecular Therapeutics?
  • What is 4D Molecular Therapeutics quarterly CFO year-on-year change?
  • What is 4D Molecular Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for 4D Molecular Therapeutics?
  • What is 4D Molecular Therapeutics TTM CFO year-on-year change?

What is 4D Molecular Therapeutics annual cash flow from operations?

The current annual CFO of FDMT is -$134.59 M

What is the all time high annual CFO for 4D Molecular Therapeutics?

4D Molecular Therapeutics all-time high annual cash flow from operations is $8.24 M

What is 4D Molecular Therapeutics annual CFO year-on-year change?

Over the past year, FDMT annual cash flow from operations has changed by -$58.79 M (-77.57%)

What is 4D Molecular Therapeutics quarterly cash flow from operations?

The current quarterly CFO of FDMT is -$45.86 M

What is the all time high quarterly CFO for 4D Molecular Therapeutics?

4D Molecular Therapeutics all-time high quarterly cash flow from operations is -$1.17 M

What is 4D Molecular Therapeutics quarterly CFO year-on-year change?

Over the past year, FDMT quarterly cash flow from operations has changed by -$15.62 M (-51.65%)

What is 4D Molecular Therapeutics TTM cash flow from operations?

The current TTM CFO of FDMT is -$134.59 M

What is the all time high TTM CFO for 4D Molecular Therapeutics?

4D Molecular Therapeutics all-time high TTM cash flow from operations is -$13.87 M

What is 4D Molecular Therapeutics TTM CFO year-on-year change?

Over the past year, FDMT TTM cash flow from operations has changed by -$49.43 M (-58.05%)